This inventor holds 1 USPTO granted patent. Top assignee: Wako Pure Chemical Industries, Inc.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Kazunisa Kubotsu: Innovator in Immunoassay Technology
Introduction
Kazunisa Kubotsu, an esteemed inventor based in Osaka, Japan, has made significant contributions to the field of immunoassay technology. His innovative approach has led to advancements that enhance diagnostic testing capabilities, ultimately benefiting various applications in healthcare.
Latest Patents
Kubotsu holds a patent for an "Immunoassay process and liquid reagents used therefor." This groundbreaking patent encompasses a combination of reagents designed to facilitate immunoassay procedures. It includes a first liquid comprising microcapsules with an analyte immobilized on their surfaces, along with microcapsules encapsulating antibodies engineered to respond uniquely to different capsule wall lysins. The second liquid contains complement, which is essential for enabling complement-dependent immune lysis of microcapsules, thus advancing the field of immunoassays.
Career Highlights
Kazunisa Kubotsu has dedicated his professional journey to Wako Pure Chemical Industries, Inc., where he applies his expertise in research and development. His innovative work has not only resulted in one patented invention but has also set new standards in the area of immunological testing.
Collaborations
In his endeavors, Kubotsu has collaborated with notable coworkers, including Masaaki Kida and Shuji Matuura. These partnerships have fostered a dynamic environment for research and innovation, contributing to the successful development of groundbreaking technologies in their field.
Conclusion
Kazunisa Kubotsu exemplifies the role of innovation in transforming diagnostic processes. His patent is a testament to his ingenuity and commitment to enhancing immunoassay technologies, paving the way for advancements that could lead to improved healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile